Drexel has recently established the Clinical and Translational Research Institute (CTRI) to foster translational, or “bench to bedside,” research throughout the University. The CTRI builds on existing strengths within Drexel, fostering collaborative translational research, while taking steps to remove impediments to the process of research translation.
The CTRI aims to substantially elevate the landscape in which biomedical research is conducted, therapeutic discoveries are made, and advances in clinical care are developed into therapeutic and commercial opportunities. The Center embraces disciplines in the fields of medicine, biotechnology, drug discovery and development, engineering, business, entrepreneurship, law and public health.
Drexel is committed to training our students to be competitive in a changing biomedical and health care environment. The CTRI maximizes this strength by creating a sustainable institutional enterprise, developing a coordinated core technology infrastructure, and generating seed funding to launch critical research initiatives.
Read the CTRI strategic plan (PDF).
The CTRI’s key objectives are:
To elevate the overall scope, infrastructure, and support for basic and clinical biomedical and life sciences research.
To provide a clear organizational center that will bridge different schools within Drexel University and support interdisciplinary research.
To increase the opportunities for Drexel physicians to engage in clinical and translational research.
To continue to develop innovative educational programs that complement translational research and that lead to new opportunities for faculty and students.
We are pleased to announce the availability of funding opportunities through the CTRI. The submissions will be required to have a focus and emphasis on translational research, and must include a clinical investigator. Funding will be available for faculty and students. Applications are now being accepted; the first awards will be granted at the end of April. Learn more about funding opportunities through the CTRI.
Genomics Core Facility
The Genomics Core Facility (GCF), under the direction of Garth D. Ehrlich, PhD, provides a wide range of genomic, bioinformatic, and other specialized and high-throughput nucleic acid-based technologies and services to Drexel faculty. The GCF specializes in high-end, cutting-edge technologies that are not part of the standard repertoire of core laboratories. It is our goal to provide an infrastructure that elevates the institution and the individual scientist-users to be technological leaders within their domain areas.
These same services are also available on a fee-for-service basis to outside clients who wish to avail themselves of these technologies. Please consult our staff when designing experiments or writing grant applications that will rely on these services.
- Resources for translational researchers
A list of other core facilities available to translational researchers
News and announcements regarding translational research at Drexel
- Director's blog
To learn more about the Clinical Translational Research Institute, please contact: